PROTEOMICS · 2008 · 130 citations · 50 references
MedicineCancer BiologyOncologyCell SignalingRadiobiologySignal TransductionCancer Cell SignalingCellular Radiation ResponseOncogenic Signaling PathwaysProstate CancerRadiation TherapySignal Transduction In CancerCancer Cell RadiosensitivityDownstream Signal TransductionEpidermal Growth Factor Receptor SignalingInositol Triphosphate SignalingMolecular Mechanisms Of RadioresistanceRadiation-induced Signaling NetworksSignal Transduction After IrradiationTumor Cell Motility
Radiation therapy plays an important role in the management of prostate carcinoma. However, the problem of radioresistance and molecular mechanisms by which prostate carcinoma cells overcome cytotoxic effects of radiation therapy remains to be elucidated. In order to investigate possible intracellular mechanisms underlying the prostate carcinoma recurrences after radiotherapy, we have established three radiation-resistant prostate cancer cell lines, LNCaP-IRR, PC3-IRR, and Du145-IRR derived from the parental LNCaP, PC3, and Du145 prostate cancer cells by repetitive exposure to ionizing radiation. LNCaP-IRR, PC3-IRR, and Du145-IRR cells (prostate carcinoma cells recurred after radiation exposure (IRR cells)) showed higher radioresistance and cell motility than parental cell lines. IRR cells exhibited higher levels of androgen and epidermal growth factor (EGF) receptors and activation of their downstream pathways, such as Ras-mitogen-activated protein kinase (MAPK) and phosphatidyl inositol 3-kinase (PI3K)-Akt and Jak-STAT. In order to define additional mechanisms involved in the radioresistance development, we determined differences in the proteome profile of parental and IRR cells using 2-D DIGE followed by computational image analysis and MS. Twenty-seven proteins were found to be modulated in all three radioresistant cell lines compared to parental cells. Identified proteins revealed capacity to interact with EGF and androgen receptors related signal transduction pathways and were involved in the regulation of intracellular routs providing cell survival, increased motility, mutagenesis, and DNA repair. Our data suggest that radioresistance development is accompanied by multiple mechanisms, including activation of cell receptors and related downstream signal transduction pathways. Identified proteins regulated in the radioresistant prostate carcinoma cells can significantly intensify activation of intracellular signaling that govern cell survival, growth, proliferation, invasion, motility, and DNA repair. In addition, such analyses may be utilized in predicting cellular response to radiotherapy.
50
Ahmedin Jemal, Rebecca L. Siegel, Elizabeth Ward et al. · CA A Cancer Journal for Clinicians · 2007 · 7.5K citations · Full text
Guideline for the Management of Clinically Localized Prostate Cancer: 2007 Update
Ian M. Thompson, J. Brantley Thrasher, Gunnar Aus et al. · The Journal of Urology · 2007 · 1.1K citations
Shuyuan Yeh, Hui‐Kuan Lin, Hong‐Yo Kang et al. · Proceedings of the National Academy of Sciences · 1999 · 589 citations